Gainers
- IVERIC bio ISEE shares moved upwards by 31.76% to $11.45 during Thursday's after-market session. Trading volume for this security closed at 1.4 million, accounting for 75.55% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion.
- Catalyst Biosciences CBIO shares increased by 11.41% to $4.88. Trading volume for this security closed at 185.7K, accounting for 65.21% of its average full-day volume over the last 100 days. The company's market cap stands at $153.0 million.
- Eli Lilly LLY stock moved upwards by 6.17% to $254.84. Eli Lilly's trading volume hit 622.5K shares by close, accounting for 22.34% of its average volume over the last 100 days. The company's market cap stands at $243.7 billion.
- Corcept Therapeutics CORT shares moved upwards by 4.01% to $22.03. This security traded at a volume of 165.7K shares come close, making up 31.52% of its average volume over the last 100 days. The market value of their outstanding shares is at $2.5 billion.
- Codexis CDXS stock moved upwards by 3.98% to $28.15. The market value of their outstanding shares is at $1.8 billion.
- Strata Skin Sciences SSKN stock moved upwards by 3.87% to $1.61. The company's market cap stands at $54.7 million.
Losers
- Gemini Therapeutics GMTX stock decreased by 7.3% to $4.7 during Thursday's after-market session. The company's market cap stands at $202.6 million.
- NGM Biopharmaceuticals NGM shares declined by 5.89% to $20.0. The market value of their outstanding shares is at $1.5 billion.
- Sera Prognostics SERA shares declined by 5.51% to $9.44. The market value of their outstanding shares is at $276.5 million.
- Innate Pharma IPHA shares declined by 3.05% to $6.06. The company's market cap stands at $479.6 million.
- Syndax Pharmaceuticals SNDX shares decreased by 1.89% to $17.72. Today's trading volume for this security ended up closing at 66.6K shares, which is 14.59 percent of its average volume over the last 100 days. The company's market cap stands at $861.6 million.
- NeuroMetrix NURO stock fell 1.86% to $11.14. The company's market cap stands at $62.7 million.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in